Amalgamated Financial vs CNB Financial
AMAL and CCNE side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AMAL and CCNE compare
Amalgamated Financial is the larger company, worth 1.4 times as much as CNB Financial ($1.5B against $1.0B).
On earnings, CNB Financial is cheaper: it trades at 11.0× trailing earnings, against 13.2× for Amalgamated Financial.
CNB Financial grew revenue faster over the last twelve months (42.0% versus 14.4% for Amalgamated Financial).
Amalgamated Financial keeps more of each dollar of sales as profit, with a net margin of 31.3% compared with 28.7% at CNB Financial.
Both pay dividends: Amalgamated Financial yields 1.4% and CNB Financial 2.2%.
CNB Financial scores higher on the StockData Score (18 against 12 for Amalgamated Financial), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AMAL | CCNE |
|---|---|---|
| Size and price | ||
| Market cap | $1.5B | $1.0B |
| Share price | $49.58 | $34.60 |
| Change, 1 year | 76.3% | 38.5% |
| Change, 5 years | 190% | 28.6% |
| Beta (5Y) | 0.31 | 0.16 |
| Employees | 450 | 950 |
| StockData Score | ||
| Total score | 12 | 18 (better) |
| Valuation score | 0 | 3 (better) |
| Growth score | 1 | 2 (better) |
| Performance score | 4 | 4 |
| Health score | 4 | 5 (better) |
| Dividend score | 3 | 4 (better) |
| Valuation | ||
| P/E | 13.2× | 11.0× (better) |
| P/S | 4.1× | 3.1× (better) |
| P/B | – | 1.1× |
| P/FCF | 10.1× (better) | 12.0× |
| PEG | 1.42 | – |
| FCF yield | 9.9% (better) | 8.4% |
| Fair value | – | $32.77 |
| Margin of safety | – | −5.6% |
| Growth | ||
| Revenue growth (TTM) | 14.4% | 42.0% (better) |
| Revenue growth, 5Y average | 8.3% | 11.6% (better) |
| Net income growth (TTM) | 9.6% | 76.4% (better) |
| EPS growth (TTM) | 12.3% | 31.9% (better) |
| EPS growth, 5Y average | 18.2% (better) | 4.8% |
| Profitability | ||
| Net margin | 31.3% (better) | 28.7% |
| FCF margin | 40.4% (better) | 25.6% |
| Return on equity | – | 12.4% |
| Financial health | ||
| Debt / equity | – | 0.22 |
| Altman Z-score | 0.23 (better) | 0.20 |
| Piotroski F-score | 6 (better) | 4 |
| Dividends and buybacks | ||
| Dividend yield | 1.4% | 2.2% (better) |
| Payout ratio | 16.6% | 22.8% |
| Years of dividend growth | – | 2 |
| Dividend growth, 5Y average | – | 1.1% |
| Buyback yield | 1.4% | – |
| Shareholder yield | 2.8% (better) | 2.2% |
| Ownership | ||
| Held by institutions | 59.0% | 66.2% |
| Held by insiders | 26.4% | 2.7% |
| Insider net buying, 12 months | −$102M | −$2.1M (better) |
| Short interest, % of float | 6.7% | – |
Go deeper
- AMAL stock overview
- AMAL income statement
- AMAL valuation and score
- CCNE stock overview
- CCNE income statement
- CCNE valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.